This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

7 Stocks Soaring on Heavy Volume

Express Scripts

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Express Scripts (ESRX) provides a range of pharmacy benefit management services in North America. This stock is trading up 8% at $60.60 in recent trading.

Today's Volume: 11.5 million

Average Volume: 5.5 million

Volume % Change: 286%

From a technical perspective, ESRX is gapping up sharply higher here with monster volume, and it's started to enter breakout territory since the stock has taken out some overhead resistance levels at $59.50 to $58.98.

>>5 Pharma Stocks Everyone Hates

Traders should now look for long-biased trades once ESRX triggers its next major breakout trade. That trade will hit once ESRX takes out its 2011 high of $60.89 with high volume. At last check, ESRX has hit an intraday high of $60.85 and volume is well above its three-month average action of 5,484,210 shares. Traders should look for a sustained move or close above 60.89 with volume that's near or above 5,484,210 shares. If we get that action soon, then look for ESRX to hit $65 to $70 in the near future.

As of the most recently reported period, Express Scripts was one of Lee Ainslie's Maverick Capital holdings and also showed up in Third Point's portfolio.

2 of 8

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,137.11 +65.89 0.39%
S&P 500 1,983.82 +6.02 0.30%
NASDAQ 4,516.36 +10.5080 0.23%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs